U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123506) titled 'Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure' on Aug. 07.
Brief Summary: "The primary objective of the study is to evaluate whether the incidence of symptomatic or asymptomatic atrial fibrillation, atrial flutter, and atrial tachycardia within 30 days after percutaneous closure of idiopathic patent foramen ovale is reduced in the beta-blocker treatment group compared to the non-treatment group.
The secondary objective is to assess the safety and performance of the Cocoon Patent Foramen Ovale Occluder and collect real-world data on patient outcomes.
Patients will be randomly assigned in a 1:1 ra...